BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32098525)

  • 1. Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacy.
    Zhai Z; Xu P; Yao J; Li R; Gong L; Yin Y; Lin Z
    Drug Deliv; 2020 Dec; 27(1):387-399. PubMed ID: 32098525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
    Sun J; Chen Y; Xu J; Song X; Wan Z; Du Y; Ma W; Li X; Zhang L; Li S
    Theranostics; 2020; 10(3):1136-1150. PubMed ID: 31938056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
    Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer.
    Araki T; Kono Y; Ogawara K; Watanabe T; Ono T; Kimura T; Higaki K
    Biol Pharm Bull; 2012; 35(8):1306-13. PubMed ID: 22863930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
    Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
    J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.
    Liang Y; Dong C; Zhang J; Deng L; Dong A
    Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma.
    Shen W; Ge S; Liu X; Yu Q; Jiang X; Wu Q; Tian Y; Gao Y; Liu Y; Wu C
    Drug Deliv; 2022 Dec; 29(1):31-42. PubMed ID: 34962215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Gao L; Wang H; Nan L; Peng T; Sun L; Zhou J; Xiao Y; Wang J; Sun J; Lu W; Zhang L; Yan Z; Yu L; Wang Y
    Bioconjug Chem; 2017 Oct; 28(10):2591-2598. PubMed ID: 28872851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
    Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
    Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
    Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q
    Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.